ZBTB45
gene geneOn this page
Also known as FLJ14486
Summary
ZBTB45 (zinc finger and BTB domain containing 45, HGNC:23715) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger and BTB domain-containing protein 45 (Q96K62). May be involved in transcriptional regulation.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Predicted to be located in nucleus. Predicted to be active in nucleoplasm.
Source: NCBI Gene 84878 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 86 total
- MANE Select transcript:
NM_001316979
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23715 |
| Approved symbol | ZBTB45 |
| Name | zinc finger and BTB domain containing 45 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14486 |
| Ensembl gene | ENSG00000119574 |
| Ensembl biotype | protein_coding |
| OMIM | 621256 |
| Entrez | 84878 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 12 protein_coding
ENST00000354590, ENST00000594051, ENST00000596739, ENST00000600130, ENST00000600990, ENST00000869554, ENST00000869555, ENST00000869556, ENST00000869557, ENST00000869558, ENST00000927208, ENST00000927209
RefSeq mRNA: 5 — MANE Select: NM_001316979
NM_001316978, NM_001316979, NM_001316981, NM_001316982, NM_032792
CCDS: CCDS12984
Canonical transcript exons
ENST00000594051 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001005546 | 58516395 | 58517673 |
| ENSE00001199356 | 58513530 | 58514310 |
| ENSE00003028970 | 58519742 | 58519810 |
Expression profiles
Bgee: expression breadth ubiquitous, 205 present calls, max score 89.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.0969 / max 55.1527, expressed in 1793 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182965 | 11.8597 | 1792 |
| 182964 | 0.2371 | 86 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 89.51 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.49 | silver quality |
| parotid gland | UBERON:0001831 | 85.81 | silver quality |
| apex of heart | UBERON:0002098 | 83.45 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.12 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.19 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.06 | gold quality |
| popliteal artery | UBERON:0002250 | 82.06 | gold quality |
| tibial artery | UBERON:0007610 | 82.03 | gold quality |
| stromal cell of endometrium | CL:0002255 | 81.92 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 81.75 | gold quality |
| skin of leg | UBERON:0001511 | 81.63 | gold quality |
| aorta | UBERON:0000947 | 81.54 | gold quality |
| right coronary artery | UBERON:0001625 | 81.45 | gold quality |
| granulocyte | CL:0000094 | 81.38 | gold quality |
| gastrocnemius | UBERON:0001388 | 81.37 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 81.33 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 81.28 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 81.25 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 81.19 | gold quality |
| lower esophagus | UBERON:0013473 | 81.18 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 81.12 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 81.10 | gold quality |
| thoracic aorta | UBERON:0001515 | 81.08 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.05 | gold quality |
| skin of abdomen | UBERON:0001416 | 81.05 | gold quality |
| ascending aorta | UBERON:0001496 | 80.98 | gold quality |
| cortical plate | UBERON:0005343 | 80.87 | gold quality |
| left coronary artery | UBERON:0001626 | 80.85 | gold quality |
| neocortex | UBERON:0001950 | 80.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.10 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting ZBTB45, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-4802-3P | 99.72 | 70.13 | 1273 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-1843 | 98.97 | 66.07 | 838 |
| HSA-MIR-4802-5P | 98.97 | 66.26 | 833 |
| HSA-MIR-589-5P | 98.72 | 66.96 | 927 |
| HSA-MIR-6787-5P | 97.54 | 63.85 | 457 |
| HSA-MIR-1910-5P | 97.42 | 66.36 | 844 |
| HSA-MIR-3943 | 95.87 | 64.57 | 523 |
| HSA-MIR-1229-5P | 94.57 | 65.78 | 487 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkeyp-84f3.5 | ENSDARG00000042989 |
| mus_musculus | Zbtb45 | ENSMUSG00000049600 |
| rattus_norvegicus | Zbtb45 | ENSRNOG00000027459 |
Paralogs (36): ZBTB32 (ENSG00000011590), SNAI2 (ENSG00000019549), PRDM1 (ENSG00000057657), PRDM6 (ENSG00000061455), ZNF76 (ENSG00000065029), PATZ1 (ENSG00000100105), MAZ (ENSG00000103495), ZBTB16 (ENSG00000109906), ZNF451 (ENSG00000112200), ZNF410 (ENSG00000119725), SNAI1 (ENSG00000124216), ZNF384 (ENSG00000126746), ZBTB1 (ENSG00000126804), VEZF1 (ENSG00000136451), PRDM14 (ENSG00000147596), ZNF276 (ENSG00000158805), ZNF362 (ENSG00000160094), ZNF653 (ENSG00000161914), ZNF281 (ENSG00000162702), ZNF148 (ENSG00000163848), ZNF143 (ENSG00000166478), HIC2 (ENSG00000169635), PRDM10 (ENSG00000170325), ZNF296 (ENSG00000170684), ZNF692 (ENSG00000171163), ZNF575 (ENSG00000176472), HIC1 (ENSG00000177374), ZBTB18 (ENSG00000179456), ZBTB42 (ENSG00000179627), ZBTB20 (ENSG00000181722), ZBTB7C (ENSG00000184828), SNAI3 (ENSG00000185669), ZFP91 (ENSG00000186660), MTF1 (ENSG00000188786), SCRT2 (ENSG00000215397), SCRT1 (ENSG00000261678)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 45 — Q96K62 (reviewed: Q96K62)
Alternative names: Zinc finger protein 499
All UniProt accessions (3): Q96K62, M0QZ57, M0R1I4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation. In the central nervous system, may play a role in glial cell differentiation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (5): NP_001303907, NP_001303908, NP_001303910, NP_001303911, NP_116181 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050457 | ZnFinger_BTB_dom_contain | Family |
Pfam: PF00096, PF00651
UniProt features (13 total): compositionally biased region 4, zinc finger region 4, region of interest 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96K62-F1 | 63.51 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 142 (showing top):
ROVERSI_GLIOMA_COPY_NUMBER_UP, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5, GOBP_CYTOKINE_PRODUCTION, HNF4_DR1_Q3, LEF1_Q6, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MODULE_49, MARTENS_TRETINOIN_RESPONSE_DN, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, PILON_KLF1_TARGETS_UP, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY
GO Biological Process (4): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682), nervous system development (GO:0007399)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| immune system process | 1 |
| regulation of biological process | 1 |
| system development | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
746 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB45 | FAM185A | Q8N0U4 | 518 |
| ZBTB45 | SLC35G4 | P0C7Q5 | 479 |
| ZBTB45 | BTBD9 | Q96Q07 | 451 |
| ZBTB45 | ZNF487 | B1APH4 | 447 |
| ZBTB45 | INAFM1 | C9JVW0 | 432 |
| ZBTB45 | C19orf47 | Q8N9M1 | 419 |
| ZBTB45 | FAM76B | Q5HYJ3 | 399 |
| ZBTB45 | TMEM134 | Q9H6X4 | 383 |
| ZBTB45 | ZHX2 | Q9Y6X8 | 381 |
| ZBTB45 | UBALD1 | Q8TB05 | 366 |
| ZBTB45 | FAM124A | Q86V42 | 358 |
| ZBTB45 | HHIPL2 | Q6UWX4 | 354 |
| ZBTB45 | XRRA1 | Q6P2D8 | 348 |
| ZBTB45 | EML3 | Q32P44 | 340 |
| ZBTB45 | TMEM209 | Q96SK2 | 333 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BAG4 | ZBTB45 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB7A | ZBTB45 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| BACH2 | ENC1 | psi-mi:“MI:0914”(association) | 0.350 |
| ORF33 | ATN1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB45 | BAG4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ftsP | ZBTB45 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZBTB45 | MED31 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): ZBTB45 (Affinity Capture-MS), MED31 (Two-hybrid), BAG4 (Two-hybrid), ZBTB45 (Affinity Capture-MS), ZBTB45 (Affinity Capture-MS), ZBTB45 (Negative Genetic), ZBTB45 (Affinity Capture-MS)
ESM2 similar proteins: A4IHR5, A6H7J1, A6NKL6, A6NL88, A7UKY7, A7YY54, B8ZZ34, C9J069, C9JLR9, E9Q1P8, O15209, O35615, O35779, P04198, P15066, P17535, P39881, P52909, Q01101, Q0PHV7, Q14526, Q14934, Q15742, Q32KV8, Q4VA45, Q52KG4, Q5TJE2, Q61976, Q63ZV0, Q6NUJ5, Q6P0F9, Q7T3H2, Q7Z5L9, Q7Z6J2, Q8C3Q5, Q8IX07, Q8R4T5, Q8TF61, Q8VCG9, Q96B18
Diamond homologs: A0A0A6YY25, B2RXH4, E0CZ16, E1B932, E7F6F9, F1LZ52, F1LZF0, F1MBP6, O88282, O93567, O95198, P10074, P17789, P42282, P42283, P42284, Q01295, Q1H9T6, Q24174, Q24206, Q3B7M1, Q52KG4, Q53G59, Q53HC5, Q5R633, Q5REP9, Q5U374, Q66HD2, Q6NRH0, Q7KQZ4, Q7KRI2, Q867Z4, Q86B87, Q8BGY4, Q8BZM0, Q8CA72, Q8IN81, Q8JZP3, Q8K0L9, Q8N143
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
86 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 5 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
670 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58514306:CTCCC:C | acceptor_gain | 1.0000 |
| 19:58514308:CCC:C | acceptor_gain | 1.0000 |
| 19:58514309:CC:C | acceptor_gain | 1.0000 |
| 19:58514309:CCC:C | acceptor_gain | 1.0000 |
| 19:58514310:CC:C | acceptor_gain | 1.0000 |
| 19:58514311:C:CC | acceptor_gain | 1.0000 |
| 19:58516390:CTCA:C | donor_loss | 1.0000 |
| 19:58516391:TCACC:T | donor_loss | 1.0000 |
| 19:58516392:CACCC:C | donor_loss | 1.0000 |
| 19:58516393:AC:A | donor_gain | 1.0000 |
| 19:58516393:ACCC:A | donor_loss | 1.0000 |
| 19:58516394:CC:C | donor_gain | 1.0000 |
| 19:58517669:GCCAT:G | acceptor_gain | 1.0000 |
| 19:58517670:CCAT:C | acceptor_gain | 1.0000 |
| 19:58517670:CCATC:C | acceptor_gain | 1.0000 |
| 19:58517671:CAT:C | acceptor_gain | 1.0000 |
| 19:58517671:CATC:C | acceptor_gain | 1.0000 |
| 19:58517672:ATCT:A | acceptor_loss | 1.0000 |
| 19:58517673:TC:T | acceptor_loss | 1.0000 |
| 19:58517674:C:CC | acceptor_gain | 1.0000 |
| 19:58517675:T:A | acceptor_loss | 1.0000 |
| 19:58519340:T:A | donor_gain | 1.0000 |
| 19:58519373:T:TA | donor_gain | 1.0000 |
| 19:58519454:T:TA | donor_gain | 1.0000 |
| 19:58519455:C:A | donor_gain | 1.0000 |
| 19:58514307:TCCC:T | acceptor_gain | 0.9900 |
| 19:58514308:CCCC:C | acceptor_gain | 0.9900 |
| 19:58514311:C:T | acceptor_gain | 0.9900 |
| 19:58514314:C:CT | acceptor_gain | 0.9900 |
| 19:58514315:G:T | acceptor_gain | 0.9900 |
AlphaMissense
3257 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58514159:G:C | H477Q | 1.000 |
| 19:58514159:G:T | H477Q | 1.000 |
| 19:58514161:G:C | H477D | 1.000 |
| 19:58514161:G:T | H477N | 1.000 |
| 19:58514169:A:G | L474P | 1.000 |
| 19:58514186:G:C | F468L | 1.000 |
| 19:58514186:G:T | F468L | 1.000 |
| 19:58514187:A:G | F468S | 1.000 |
| 19:58514188:A:G | F468L | 1.000 |
| 19:58514188:A:T | F468I | 1.000 |
| 19:58514200:A:G | C464R | 1.000 |
| 19:58514207:G:C | C461W | 1.000 |
| 19:58514209:A:G | C461R | 1.000 |
| 19:58514213:G:C | F459L | 1.000 |
| 19:58514213:G:T | F459L | 1.000 |
| 19:58514215:A:G | F459L | 1.000 |
| 19:58514231:G:C | H453Q | 1.000 |
| 19:58514231:G:T | H453Q | 1.000 |
| 19:58514233:G:C | H453D | 1.000 |
| 19:58514243:G:C | H449Q | 1.000 |
| 19:58514243:G:T | H449Q | 1.000 |
| 19:58514245:G:C | H449D | 1.000 |
| 19:58514245:G:T | H449N | 1.000 |
| 19:58514253:A:G | L446P | 1.000 |
| 19:58514270:G:C | F440L | 1.000 |
| 19:58514270:G:T | F440L | 1.000 |
| 19:58514271:A:G | F440S | 1.000 |
| 19:58514272:A:G | F440L | 1.000 |
| 19:58514282:G:C | C436W | 1.000 |
| 19:58514283:C:T | C436Y | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000009784 (19:58527218 C>G), RS1000017709 (19:58544053 C>T), RS1000064811 (19:58526962 G>C), RS1000091034 (19:58513695 C>G), RS1000121357 (19:58531596 T>C), RS1000130008 (19:58521018 C>G,T), RS1000136372 (19:58520816 G>A), RS1000243302 (19:58532554 CT>C,CTT), RS1000441607 (19:58513878 G>A,T), RS1000466163 (19:58532923 C>T), RS1000618511 (19:58543087 T>C,G), RS1000644493 (19:58521374 AAAAAAAAAAAG>A), RS1000857965 (19:58520518 G>A,T), RS1001006526 (19:58538188 C>T), RS1001022050 (19:58527142 T>C)
Disease associations
OMIM: gene MIM:621256 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 3 |
| Arsenic | affects methylation, increases abundance, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | decreases sumoylation | 1 |
| dicrotophos | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| clothianidin | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Bucladesine | increases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Theophylline | affects cotreatment, decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Medroxyprogesterone Acetate | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A8A8 | SEES3-1V human ZBTB45, clone1 | Embryonic stem cell | Male |
| CVCL_A8A9 | SEES3-1V human ZBTB45, clone2 | Embryonic stem cell | Male |
| CVCL_A8B0 | SEES3-1V human ZBTB45, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.